HAS2 and breast carcinoma: Saito et al. also reported that 4-MU inhibited cell proliferation and induced apoptosis in breast cancer cells together with inhibiting HA synthesis accompanied by downregulation of HAS2 mRNA levels in a dose-depending manner [28].